Serum thrombopoietin levels in thrombocytopenic and non-thrombocytopenic patients with human immunodeficiency virus (HIV-1) infection

: HIV‐1 seropositive patients often exhibit thrombocytopenia, considered of multifactorial aetiology. Thrombopoietin (TPO), a recently isolated cytokine, is the main regulator of megakaryocyte and platelet production. The objective of this study was to analyse serum TPO levels in thrombocytopenic an...

Full description

Saved in:
Bibliographic Details
Published in:European journal of haematology 1999-10, Vol.63 (4), p.245-250
Main Authors: Español, I., Muñiz-Diaz, E., Margall, N., Rabella, N., Sambeat, M.-A., Hernández, A., Pujol-Moix, N.
Format: Article
Language:English
Subjects:
Acquired Immunodeficiency Syndrome - blood
Adult
AIDS/HIV
autoimmune thrombocytopenic purpura (AITP)
Biological and medical sciences
Blood Platelets - physiology
Female
Hematopoiesis - physiology
HIV-1
human immunodeficiency virus (HIV)
Human viral diseases
Humans
Infectious diseases
Male
Medical sciences
Megakaryocytes - physiology
Reference Values
thrombocytopenia
Thrombocytopenia - blood
thrombopoietin
Thrombopoietin - blood
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:: HIV‐1 seropositive patients often exhibit thrombocytopenia, considered of multifactorial aetiology. Thrombopoietin (TPO), a recently isolated cytokine, is the main regulator of megakaryocyte and platelet production. The objective of this study was to analyse serum TPO levels in thrombocytopenic and non‐thrombocytopenic HIV‐1 infected patients. Serum TPO levels were measured by ELISA in 43 healthy individuals and in 88 HIV‐1 infected patients: 68 thrombocytopenics and 20 non‐thrombocytopenics. Thrombocytopenic HIV‐1 infected patients showed higher TPO concentrations (263 ± 342 pg/ml) than non‐thrombocytopenics (191 ± 86 pg/ml); levels in both groups were significantly higher than those of healthy controls (121 ± 58 pg/ml). Two subgroups of thrombocytopenic patients, the autoimmune thrombocytopenic purpura (AITP) group and the mild thrombocytopenic group, presented TPO levels similar to those of non‐thrombocytopenics. Patients exhibiting pancytopenia showed the highest TPO concentrations. However, there was no correlation between TPO levels and platelet counts in any group of HIV‐1 infected patients. TPO levels in HIV‐1 seropositive patients were slightly increased and the differences in TPO levels between thrombocytopenic and non‐thrombocytopenic patients were generally small. The finding of mildly increased TPO levels along with the recently described recovery of thrombocytopenia following recombinant TPO administration confirms the implication of ineffective platelet production in the origin of HIV‐associated thrombocytopenia.
ISSN:0902-4441
1600-0609
DOI:10.1111/j.1600-0609.1999.tb01885.x